Conference Preview｜The 10th China Fetal Medicine Conference

(Summary description)

Categories:Industry form
Author:
Origin:
Time of issue:2020-09-14
Views:0

Meeting information

Meeting form:

On-site participation + online live broadcast

Meeting time:

Registration time:

September 17, 2020 (Thursday) [On-site participants only]

meeting time:

September 18-19, 2020 (Friday-Saturday)

Registration and meeting place:

The Longemont Hotel Shanghai (No. 1116, West Yan'an Road, Changning District, Shanghai) [On-site participants only]

Participation method:

1. Please follow and enter the official WeChat public account "Bruce Medical Conference", click on the footer navigation bar "CCFM" to enter the conference page to register and pay.

2. Please use the mobile phone number registered during registration to watch the live broadcast.

Meeting schedule

Special meeting

Zhu

precious

pregnancy

teach

Grant

Director of the Medical Genetics Department of the First People's Hospital of Yunnan Province

Speech time:

September 18, 2020 (Friday) 12:45-13:00

Speech topic:

The extended application of prenatal screening---pre-eclampsia risk prediction and early warning

Speaker profile:

Executive Deputy Director of the Key Laboratory of Western Preconception Eugenics, National Health Commission

Member of the National Training Expert Group for Birth Defects Prevention and Treatment of the National Health Commission

Vice President of Chinese Eugenics Science Association

Member of the Standing Committee of the Medical Genetics Committee of the Chinese Medical Association

Member of the Standing Committee of the Medical Genetics Physician Branch of the Chinese Medical Doctor Association

About Aocheng

Ningbo Aocheng Biotechnology Co., Ltd. is a high-tech biological enterprise focusing on the early detection, diagnosis, prevention and monitoring of diseases. By providing reliable, fast and convenient in vitro diagnostic products, it can provide accurate test results for diagnosis and treatment.

At present, the company's biomedical team continues to conduct in-depth exploration and prospective research in the field of high-risk diseases for pregnant women such as hypertension.We will be committed to providing leading clinical diagnosis solutions for women and children's health. Promote the standardized management of perinatal preeclampsia in my country, and contribute to the predictive management of preeclampsia in the world.